The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Plasma Fraction Market Research Report 2024
Synopsis
Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.
The global Plasma Fraction market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Plasma Fraction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fraction.
Report Scope
The Plasma Fraction market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Fraction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Fraction companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Octapharma
Biotest
CSL
Grifols
Kedrion
LFB
Chinese Biological Products
Shanghai RAAS Blood Products
Segment by Type
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Fraction companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.
The global Plasma Fraction market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Plasma Fraction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fraction.
Report Scope
The Plasma Fraction market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Fraction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Fraction companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Octapharma
Biotest
CSL
Grifols
Kedrion
LFB
Chinese Biological Products
Shanghai RAAS Blood Products
Segment by Type
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Fraction companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Fraction Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protease Inhibitors
1.2.3 Protease
1.2.4 Fibrinolytic Proteins
1.2.5 Coagulation Factors
1.2.6 Anti-Coagulant Proteins
1.3 Market by Application
1.3.1 Global Plasma Fraction Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Fraction Market Perspective (2019-2030)
2.2 Plasma Fraction Growth Trends by Region
2.2.1 Global Plasma Fraction Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plasma Fraction Historic Market Size by Region (2019-2024)
2.2.3 Plasma Fraction Forecasted Market Size by Region (2025-2030)
2.3 Plasma Fraction Market Dynamics
2.3.1 Plasma Fraction Industry Trends
2.3.2 Plasma Fraction Market Drivers
2.3.3 Plasma Fraction Market Challenges
2.3.4 Plasma Fraction Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Fraction Players by Revenue
3.1.1 Global Top Plasma Fraction Players by Revenue (2019-2024)
3.1.2 Global Plasma Fraction Revenue Market Share by Players (2019-2024)
3.2 Global Plasma Fraction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma Fraction Revenue
3.4 Global Plasma Fraction Market Concentration Ratio
3.4.1 Global Plasma Fraction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Fraction Revenue in 2023
3.5 Plasma Fraction Key Players Head office and Area Served
3.6 Key Players Plasma Fraction Product Solution and Service
3.7 Date of Enter into Plasma Fraction Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Fraction Breakdown Data by Type
4.1 Global Plasma Fraction Historic Market Size by Type (2019-2024)
4.2 Global Plasma Fraction Forecasted Market Size by Type (2025-2030)
5 Plasma Fraction Breakdown Data by Application
5.1 Global Plasma Fraction Historic Market Size by Application (2019-2024)
5.2 Global Plasma Fraction Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plasma Fraction Market Size (2019-2030)
6.2 North America Plasma Fraction Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plasma Fraction Market Size by Country (2019-2024)
6.4 North America Plasma Fraction Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Fraction Market Size (2019-2030)
7.2 Europe Plasma Fraction Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plasma Fraction Market Size by Country (2019-2024)
7.4 Europe Plasma Fraction Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma Fraction Market Size (2019-2030)
8.2 Asia-Pacific Plasma Fraction Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plasma Fraction Market Size by Region (2019-2024)
8.4 Asia-Pacific Plasma Fraction Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasma Fraction Market Size (2019-2030)
9.2 Latin America Plasma Fraction Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plasma Fraction Market Size by Country (2019-2024)
9.4 Latin America Plasma Fraction Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Fraction Market Size (2019-2030)
10.2 Middle East & Africa Plasma Fraction Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plasma Fraction Market Size by Country (2019-2024)
10.4 Middle East & Africa Plasma Fraction Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Detail
11.1.2 Baxter Business Overview
11.1.3 Baxter Plasma Fraction Introduction
11.1.4 Baxter Revenue in Plasma Fraction Business (2019-2024)
11.1.5 Baxter Recent Development
11.2 Octapharma
11.2.1 Octapharma Company Detail
11.2.2 Octapharma Business Overview
11.2.3 Octapharma Plasma Fraction Introduction
11.2.4 Octapharma Revenue in Plasma Fraction Business (2019-2024)
11.2.5 Octapharma Recent Development
11.3 Biotest
11.3.1 Biotest Company Detail
11.3.2 Biotest Business Overview
11.3.3 Biotest Plasma Fraction Introduction
11.3.4 Biotest Revenue in Plasma Fraction Business (2019-2024)
11.3.5 Biotest Recent Development
11.4 CSL
11.4.1 CSL Company Detail
11.4.2 CSL Business Overview
11.4.3 CSL Plasma Fraction Introduction
11.4.4 CSL Revenue in Plasma Fraction Business (2019-2024)
11.4.5 CSL Recent Development
11.5 Grifols
11.5.1 Grifols Company Detail
11.5.2 Grifols Business Overview
11.5.3 Grifols Plasma Fraction Introduction
11.5.4 Grifols Revenue in Plasma Fraction Business (2019-2024)
11.5.5 Grifols Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Detail
11.6.2 Kedrion Business Overview
11.6.3 Kedrion Plasma Fraction Introduction
11.6.4 Kedrion Revenue in Plasma Fraction Business (2019-2024)
11.6.5 Kedrion Recent Development
11.7 LFB
11.7.1 LFB Company Detail
11.7.2 LFB Business Overview
11.7.3 LFB Plasma Fraction Introduction
11.7.4 LFB Revenue in Plasma Fraction Business (2019-2024)
11.7.5 LFB Recent Development
11.8 Chinese Biological Products
11.8.1 Chinese Biological Products Company Detail
11.8.2 Chinese Biological Products Business Overview
11.8.3 Chinese Biological Products Plasma Fraction Introduction
11.8.4 Chinese Biological Products Revenue in Plasma Fraction Business (2019-2024)
11.8.5 Chinese Biological Products Recent Development
11.9 Shanghai RAAS Blood Products
11.9.1 Shanghai RAAS Blood Products Company Detail
11.9.2 Shanghai RAAS Blood Products Business Overview
11.9.3 Shanghai RAAS Blood Products Plasma Fraction Introduction
11.9.4 Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2019-2024)
11.9.5 Shanghai RAAS Blood Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
